Delphia (USA)’s Qiagen QGEN Stock Holding History

Delphia (USA)’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-7,736	Closed	-$387K	–	396
2022 Q2	$387K	Buy	7,736 +3,300	+74%	+$161K	0.27%	121
2022 Q1	$230K	Buy	+4,436	New	+$229K	0.17%	233

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Delphia (USA)'s QGEN Position: Q3 2022 in Review

Delphia (USA) sold out of Qiagen (QGEN) in Q3 2022, closing a stake of 7,736 shares — an estimated $387K sold.

Delphia (USA) first reported a position in QGEN in Q1 2022 and held it in 2 quarters. The position peaked at $387K in Q2 2022. 295 funds tracked by Wall St. Rank hold QGEN as of Q3 2022.

Delphia (USA) reported no remaining Qiagen position as of Q3 2022 after selling out during the quarter.
Delphia (USA) sold 7,736 Qiagen shares in Q3 2022, an estimated $387K.
Delphia (USA) first reported a position in Qiagen in Q1 2022 and held it in 2 quarters.
Delphia (USA)'s Qiagen position peaked at $387K in Q2 2022.
295 funds tracked by Wall St. Rank held Qiagen as of Q3 2022.

Based on Delphia (USA)'s 13F filing for Q3 2022, filed 14 Nov 2022.